期刊的影响因子--文章列表

期刊文章列表
Pengcheng Wang，Guangyi Zeng，Yu Yan，Song-yang Zhang，Yongqiang Dong，Yangming Zhang，Xingzhong Zhang，Huiying Liu，Zhipeng Zhang，Changtao Jiang，Yanli Pang（Department of Physiology and Pathophysiology；Center of Basic Medical Research；Center for Reproductive Medicine；Center for Obesity and Metabolic Disease Research；General Surgery Department）.Disruption of adipocyte HIF-1α improves atherosclerosis through the inhibition of ceramide generation[J].药学学报:英文版,2022,第4期 Lei Feng，Xiangge Tian，Dahong Yao，Zhenlong Yu，Xiaokui Huo，Zhenhao Tian，Jing Ning，Jingnan Cui，Tony D.James，Xiaochi Ma（Second Affiliated Hospital；College of Pharmacy；School of Pharmaceutical Sciences；State Key Laboratory of Fine Chemicals；Department of Chemistry；School of Chemistry and Chemical Engineering）.A practical strategy to develop isoform-selective near-infrared fluorescent probes for human cytochrome P450 enzymes[J].药学学报:英文版,2022,第4期 Lingxin Hou，Ying Zhang，Han Ju，Srinivasulu Cherukupalli，Ruifang Jia，Jian Zhang，Bing Huang，Arianna Loregian，Xinyong Liu，Peng Zhan（Department of Medicinal Chemistry；Institute of Poultry Science；Department of Molecular Medicine；China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province；Institute of Medical Sciences）.Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins[J].药学学报:英文版,2022,第4期 Chunlong Ma，Haozhou Tan，Juliana Choza，Yuyin Wang，Jun Wang（Department of Pharmacology and Toxicology）.Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays[J].药学学报:英文版,2022,第4期 Jie Zhou，Wei Xu，Zezhong Liu，Chao Wang，Shuai Xia，Qiaoshuai Lan，Yanxing Cai，Shan Su，Jing Pu，Lixiao Xing，Youhua Xie，Lu Lu，Shibo Jiang，Qian Wang（Key Laboratory of Medical Molecular Virology（MOE/NHC/CAMS）；State Key Laboratory of Toxicology and Medical Countermeasures）.A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases[J].药学学报:英文版,2022,第4期 Chuanbin Yang，Chengfu Su，Ashok Iyaswamy，Senthil Kumar Krishnamoorthi，Zhou Zhu，Sichang Yang，Benjamin Chunkit Tong，Jia Liu，Sravan G.Sreenivasmurthy，Xinjie Guan，Yuxuan Kan，Aston Jiaxi Wu，Alexis Shiying Huang，Jieqiong Tan，Kingho Cheung，Juxian Song，Min Li（Mr.&Mrs.Ko Chi-Ming Centre for Parkinson’s Disease Research；Department of Geriatrics；Institute for Research and Continuing Education；College of Pharmacy；Center for Medical Genetics and Hunan Key Laboratory of Animal Model for Human Diseases；Medical College of Acupuncture-Moxibustion and Rehabilitation）.Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology：Implications for Alzheimer's disease therapy[J].药学学报:英文版,2022,第4期 Minsong Guo，Fengdan Zhu，Wenqiao Qiu，Gan Qiao，Betty Yuen-Kwan Law，Lu Yu，Jianming Wu，Yong Tang，Chonglin Yu，Dalian Qin，Xiaogang Zhou，Anguo Wu（Sichuan Key Medical Laboratory of New Drug Discovery and Druggability Evaluation；State Key Laboratory of Quality Research in Chinese Medicine；Department of Neurosurgery Sichuan Provincial People’s Hospital）.High-throughput screening for amyloid-β binding natural small-molecules based on the combinational use of biolayer interferometry and UHPLC−DAD-Q/TOF-MS/MS[J].药学学报:英文版,2022,第4期 Minyang Fu，Dandan Peng，Tianxia Lan，Yuquan Wei，Xiawei Wei（Laboratory of Aging Research and Cancer Drug Target）.Multifunctional regulatory protein connective tissue growth factor (CTGF)：A potential therapeutic target for diverse diseases[J].药学学报:英文版,2022,第4期 Tiecheng Zhong，Wenxin Zhang，Hongjie Guo，Xiaohui Pan，Xi Chen，Qiaojun He，Bo Yang，Ling Ding（Zhejiang Province Key Laboratory of Anti-Cancer Drug Research）.The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies[J].药学学报:英文版,2022,第4期 Hui Liu，Weimin Qiu，Tianyu Sun，Lei Wang，Chenxi Du，Yanyu Hu，Wenyuan Liu，Feng Feng，Yao Chen，Haopeng Sun（School of Pharmacy；School of Pharmacy；Jiangsu Drug Development Engineering Research Center for Central Degenerative Disease；Department of Natural Medicinal Chemistry；Department of Pharmaceutical Analysis）.Therapeutic strategies of glioblastoma (GBM)：The current advances in the molecular targets and bioactive small molecule compounds[J].药学学报:英文版,2022,第4期 Jun Wang，Yanmei Hu，Madeleine Zheng（Department of Pharmacology and Toxicology）.Enterovirus A71 antivirals：Past,present,and future[J].药学学报:英文版,2022,第4期 Mengqi Xu，Cong Mao，Haoting Chen，Lu Liu，Yabin Wang，Abid Hussain，Sulei Li，Xu Zhang，Ruslan G.Tuguntaev，Xing-Jie Liang，Weisheng Guo，Feng Cao（Department of Cardiology；Department of Minimally Invasive Interventional Radiology；Laboratory of Controllable Nanopharmaceuticals；Department of Urology）.Osteopontin targeted theranostic nanoprobes for laser-induced synergistic regression of vulnerable atherosclerotic plaques[J].药学学报:英文版,2022,第4期 Yongrong Yao，Huachao Chen，Ninghua Tan（State Key Laboratory of Natural Medicines）.Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy[J].药学学报:英文版,2022,第4期 Zhiqiang Deng，Yu Dong，Xiaoting Zhou，Jia-Hong Lu，Zhenyu Yue（State Key Laboratory of Quality Research in Chinese Medicine；Department of Neurology；Department of Geriatrics）.Pharmacological modulation of autophagy for Alzheimer's disease therapy：Opportunities and obstacles[J].药学学报:英文版,2022,第4期 Guangdi Li，Yali Wang，Erik De Clercq（Hunan Provincial Key Laboratory of Clinical Epidemiology；Rega Institute for Medical Research）.Approved HIV reverse transcriptase inhibitors in the past decade[J].药学学报:英文版,2022,第4期 Zhiwei Zhang，Suling Ding，Zhe Wang，Xiaowei Zhu，Zheliang Zhou，Weiwei Zhang，Xiangdong Yang，Junbo Ge（Institutes of Biomedical Sciences and Shanghai Institute of Cardiovascular Diseases；Reproductive Medicine Centre；Department of Cardiology；NHC Key Laboratory of Viral Heart Diseases；Key Laboratory of Viral Heart Diseases）.Prmt1 upregulated by Hdc deficiency aggravates acute myocardial infarction via NETosis[J].药学学报:英文版,2022,第4期 Hong Wang，Qianqian Wang，Guodi Cai，Zhijian Duan，Zoann Nugent，Jie Huang，Jianwei Zheng，Alexander D.Borowsky，Jian Jian Li，Peiqing Liu，Hsing-Jien Kung，Leigh Murphy，Hong-Wu Chen，Junjian Wang（School of Pharmaceutical Sciences；Department of Biochemistry and Molecular Medicine；Research Institute in Oncology and Hematology；Guangdong Lung Cancer Institute；Department of Pathology and Laboratory Medicine；Department of Radiation Oncology；National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation；UC Davis Comprehensive Cancer Center）.Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop via NRF2 in cancer therapeutic resistance[J].药学学报:英文版,2022,第4期 Shuai Guo，Kening Li，Yanwen Chen，Bin Li（State Key Laboratory of Natural Medicines and School of Traditional Chinese Pharmacy）.Unraveling the drug distribution in brain enabled by MALDI MS imaging with laser-assisted chemical transfer[J].药学学报:英文版,2022,第4期 Tengfei Xue，Juan Ji，Yuqin Sun，Xinxin Huang，Zhenyu Cai，Jin Yang，Wei Guo，Ruobing Guo，Hong Cheng，Xiulan Sun（Department of Pharmacology；Nanjing University of Chinese Medicine；The First Affiliated Hospital of Nanjing Medical University）.Sphingosine-1-phosphate,a novel TREM2 ligand,promotes microglial phagocytosis to protect against ischemic brain injury[J].药学学报:英文版,2022,第4期 Hsiang-i Tsai，Yanping Wu，Rui Huang，Dandan Su，Yingyi Wu，Xiaoyan Liu，Linglu Wang，Zhanxue Xu，Yuxin Pang，Chong Sun，Chao He，Fan Shu，Haitao Zhu，Dongqing Wang，Fang Cheng，Laiqiang Huang，Hongbo Chen（School of Pharmaceutical Sciences（Shenzhen）；Department of Medical Imaging；Department of Hematology；The Shenzhen Key Lab of Gene and Antibody Therapy；School of Traditional Medicine Materials Resource；Immune Regulation in Cancer）.PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia[J].药学学报:英文版,2022,第4期 Wen-Xing Ding，Russell H.Swerdlow（Department of Pharmacology；Department of Neurology）.Editorial of special column on Drug targets and drug development for Alzheimer's disease[J].药学学报:英文版,2022,第4期 Zhidi Pan，Jie Chen，Xiaodong Xiao，Yueqing Xie，Hua Jiang，Baohong Zhang，Huili Lu，Yunsheng Yuan，Lei Han，Yuexian Zhou，Huifang Zong，Lei Wang，Rui Sun，Jianwei Zhu（Engineering Research Center of Cell&Therapeutic Antibody；Jecho Laboratories；Jecho Biopharmaceuticals Co.）.Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement[J].药学学报:英文版,2022,第4期 Zhiwei Xiao，Huiyi Wei，Yi Xu，Ahmed Haider，Junjie Wei，Shiyu Yuan，Jian Rong，Chunyu Zhao，Guocong Li，Weibin Zhang，Huangcan Chen，Yuefeng Li，Lingling Zhang，Jiyun Sun，Shaojuan Zhang，Hai-Bin Luo，Sen Yan，Qijun Cai，Lu Hou，Chao Che，Steven H.Liang，Lu Wang（Center of Cyclotron and PET Radiopharmaceuticals；Division of Nuclear Medicine and Molecular Imaging；Department of Cardiology；State Key Laboratory of Chemical Oncogenomics；Guangdong Landau Biotechnology Co.Ltd.；Key Laboratory of Tropical Biological Resources of Ministry of Education；Guangdong-Hongkong-Macao Institute of CNS Regeneration）.Discovery of a highly specific ¹⁸F-labeled PET ligand for phosphodiesterase 10A enabled by novel spirocyclic iodonium ylide radiofluorination[J].药学学报:英文版,2022,第4期 Xueqin He，Xiaorong Wang，Lianyi Yang，Zhihang Yang，Wenqi Yu，Yazhen Wang，Rui Liu，Meiwan Chen，Huile Gao（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province；State Key Laboratory of Quality Research in Chinese Medicine）.Intelligent lesion blood–brain barrier targeting nano-missiles for Alzheimer's disease treatment by anti-neuroinflammation and neuroprotection[J].药学学报:英文版,2022,第4期 Zhong Li，Jimin Xu，Yuekun Lang，Xiangmeng Wu，Saiyang Hu，Subodh Kumar Samrat，Anil M.Tharappel，Lili Kuo，David Butler，Yongcheng Song，Qing-Yu Zhang，Jia Zhou，Hongmin Li（Department of Pharmacology and Toxicology；Wadsworth Center；Chemical Biology Program；The Neural Stem Cell Institute；Department of Pharmacology and Chemical Biology）.In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus[J].药学学报:英文版,2022,第4期 Sameera Senaweera，Tiffany C.Edwards，Jayakanth Kankanala，Yan Wang，Rajkumar Lalji Sahani，Jiashu Xie，Robert J.Geraghty，Zhengqiang Wang（Center for Drug Design；Translational Medicine R&D Center）.Discovery of N-benzyl hydroxypyridone carboxamides as a novel and potent antiviral chemotype against human cytomegalovirus (HCMV)[J].药学学报:英文版,2022,第4期 Yunlong Shan，Qi Ni，Qixiang Zhang，Mengying Zhang，Bin Wei，Lingge Cheng，Chongjin Zhong，Xinyu Wang，Qingqing Wang，Jiali Liu，Jingwei Zhang，Jingjing Wu，Guangji Wang，Fang Zhou（Key Laboratory of Drug Metabolism and Pharmacokinetics；Department of Hematology and Oncology）.Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment[J].药学学报:英文版,2022,第4期 Saba R.Aliyari，Amir Ali Ghaffari，Olivier Pernet，Kislay Parvatiyar，Yao Wang，Hoda Gerami，Ann-Jay Tong，Laurent Vergnes，Armin Takallou，Adel Zhang，Xiaochao Wei，Linda D.Chilin，Yuntao Wu，Clay F.Semenkovich，Karen Reue，Stephen T.Smale，Benhur Lee，Genhong Cheng（Department of Microbiology；EnViro International Laboratories；Department of Human Genetics；Division of Endocrinology；Center for Infectious Disease Research；Diabetic Cardiovascular Disease Center）.Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2[J].药学学报:英文版,2022,第4期 Jun Wang，Hongmin Li（Department of Medicinal Chemistry；Department of Pharmacology and Toxicology）.Editorial of Special Column on Antiviral Drug Discovery and Pharmacology[J].药学学报:英文版,2022,第4期首页上一页 5 6 7 8 9 下一页尾页共有11页，转到页

期刊文章列表